The Rising Need for Efficient and Effective Drug Discoveries Worldwide is Expected to Create Lucrative Growth Opportunities in the Market.
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
Banco Santander increased its stake in Danaher by 56.2%, now holding 8,757 shares worth $2.01 million. Several other ...
AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...
Why Is Danaher Corporation’s Stock Showing Market Fluctuations?
Diamond Hill Small Cap Strategy portfolio outperformed the Russell 2000 Index in Q4 and for the full year. Click here to read ...
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter ...
Persistent softness in the Life Sciences segment weighs on DHR's performance. An increase in operating expenses is an added ...
Shares of Danaher Corp. DHR slipped 3.23% to $205.23 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...
Shares of Danaher Corp. DHR slid 1.28% to $212.07 Friday, on what proved to be an all-around positive trading session for the ...
Danaher Corporation (NYSE:DHR) is a diversified company that makes medical, industrial, and commercial products. It mostly ...
Torray Investment Partners LLC reduced its stake in Danaher by 6.5%, selling 1,287 shares in Q4. Despite this, institutional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results